PRESENTATION

Q1 2020 — Presentation

Q1 2020PDF · 14 pages153 KB
Kathy Warden
Chairman, Chief Executive Officer and
President
Northrop Grumman First Quarter
2020 Conference Call
April 29, 2020
1
Dave Keffer
Corporate Vice President and Chief
Financial Officer

-- 1 of 14 --

Forward-Looking Statement
This presentation and the information we are incorporating by reference, and statements to be made on the earnings conference call, contain or may contain statements that constitute
“forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Words such as “will,” “expect,” “anticipate,” “intend,” “may,” “could,” “should,”
“plan,” “project,” “forecast,” “believe,” “estimate,” “guidance,” “outlook,” “trends,” “goals” and similar expressions generally identify these forward-looking statements.
Forward-looking statements include, among other things, statements relating to our future financial condition, results of operations and/or cash flows. Forward-looking statements are
based upon assumptions, expectations, plans and projections that we believe to be reasonable when made, but which may change over time. These statements are not guarantees of
future performance and inherently involve a wide range of risks and uncertainties that are difficult to predict. Specific risks that could cause actual results to differ materially from those
expressed or implied in these forward-looking statements include, but are not limited to, those identified and discussed more fully in the section entitled “Risk Factors” in the Form 10-K for
the year ended December 31, 2019, the section entitled “Risk Factors” in the Form 10-Q for the quarter ended March, 31 2020 and from time to time in our other filings with the Securities
and Exchange Commission (SEC). These risks and uncertainties are amplified by the global COVID-19 pandemic, which has caused and will continue to cause significant challenges,
instability and uncertainty. They include:
– 	the impact of the COVID-19 outbreak or future epidemics on our business, including the potential for worker absenteeism, facility closures, work slowdowns or stoppages, supply
chain disruptions, program delays, our ability to recover costs under contracts, changing government funding and acquisition priorities and processes, changing government payment
rules and practices, and potential impacts on access to capital, the markets and the fair value of our assets;
– 	our dependence on the U.S. government for a substantial portion of our business
– 	significant delays or reductions in appropriations for our programs, and U.S. government funding and program support more broadly
– 	investigations, claims, disputes, enforcement actions, litigation and/or other legal proceedings
– 	the use of estimates when accounting for our contracts and the effect of contract cost growth and/or changes in estimated contract revenues and costs
– 	our exposure to additional risks as a result of our international business, including risks related to geopolitical and economic factors, suppliers, laws and regulations
– 	the improper conduct of employees, agents, subcontractors, suppliers, business partners or joint ventures in which we participate and the impact on our reputation and our ability to do
business
– 	cyber and other security threats or disruptions faced by us, our customers or our suppliers and other partners
– 	the performance and financial viability of our subcontractors and suppliers and the availability and pricing of raw materials and components
– 	changes in procurement and other laws, regulations, contract terms and practices applicable to our industry, findings by the U.S. government as to our compliance with such
requirements, and changes in our customers’ business practices globally
– 	increased competition within our markets and bid protests
– 	the ability to maintain a qualified workforce with the required security clearances and requisite skills
– 	our ability to meet performance obligations under our contracts, including obligations that require innovative design capabilities, are technologically complex, require certain
manufacturing expertise or are dependent on factors not wholly within our control
– 	environmental matters, including unforeseen environmental costs and government and third party claims
– 	natural disasters
– 	health epidemics, pandemics and similar outbreaks, including the global COVID-19 pandemic
– 	the adequacy and availability of our insurance coverage, customer indemnifications or other liability protections
– 	products and services we provide related to hazardous and high risk operations, including the production and use of such products, which subject us to various environmental,
regulatory, financial, reputational and other risks
– 	the future investment performance of plan assets, changes in actuarial assumptions associated with our pension and other postretirement benefit plans and legislative or other
regulatory actions impacting our pension and postretirement benefit obligations
– 	our ability appropriately to exploit and/or protect intellectual property rights
– 	our ability to develop new products and technologies and maintain technologies, facilities, and equipment to win new competitions and meet the needs of our customers
– 	unanticipated changes in our tax provisions or exposure to additional tax liabilities
– 	changes in business conditions that could impact business investments and/or recorded goodwill or the value of other long-lived assets
You are urged to consider the limitations on, and risks associated with, forward-looking statements and not unduly rely on the accuracy of forward-looking statements. These forward-
looking statements speak only as of the date this presentation is first issued or, in the case of any document incorporated by reference, the date of that document. We undertake no
obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by applicable law.
This presentation also contains non-GAAP financial measures. A reconciliation to the nearest GAAP measure and a discussion of the company’s use of these measures are included in
this presentation.
2

-- 2 of 14 --

Q1 2020 Highlights
• 	Sales +5% to $8.6 billion
• 	11.1% Segment OM% (1)
• 	$7.9 billion net awards
• 	Strong $64.2 billion total backlog
• 	COVID-19 impacts:
– 	Not material to Q1 segment results
– 	Negative market returns impacted EPS
• 	Sales and MTM-adjusted EPS (1) guidance updated for Q1 financial
impact and expected COVID-19-related impacts going forward
• 	Segment OM% (1) and Free Cash Flow (1) guidance maintained
3
(1) Non-GAAP metric. See Appendix.
Solid Q1 operating results

-- 3 of 14 --

Net Pension 	0.48
Marketable Securities Loss 	(0.48)
Tax and Other 	0.09
Q1 2019 EPS 	$5.06
Q1 2020 EPS 	$5.15
Q1 2020 EPS Bridge
4
(1) Includes negative returns on marketable securities related to non-qualified benefit plans and other non-operating assets.
(1)
Bridge items using 21% tax rate
$5.06 	$5.15
0.00
1.00
2.00
3.00
4.00
5.00
6.00
Q1
2019 	2020

-- 4 of 14 --

Sales
5
Strong sales growth
($ millions) 	Q1 2019 	Q1 2020 	Change
Aeronautics Systems 	2,818 	2,843 	1%
Defense Systems 	1,768 	1,881 	6%
Mission Systems 	2,210 	2,347 	6%
Space Systems 	1,801 	1,948 	8%
Intersegment Elims 	(408) 	(399)
Total Sales 	8,189 	8,620 	5%
$8.2 $8.6
0.0
1.0
2.0
3.0
4.0
5.0
6.0
7.0
8.0
9.0
10.0
Q1
2019 	2020
$B

-- 5 of 14 --

Segment Operating Income(1)
6
($ millions) 	Q1 2019 	Q1 2020 	% Change
Aeronautics Systems 	308 	259 	(16%)
Defense Systems 	202 	196 	(3%)
Mission Systems 	319 	348 	9%
Space Systems 	188 	199 	6%
Intersegment Elims 	(50) 	(49)
Segment Operating
Income(1) 	967 	953 	(1%)
Segment operating income(1) guidance maintained
$967 	$953
0
200
400
600
800
1,000
1,200
Q1
2019 	2020
$M
(1) Non-GAAP metric. See Appendix.

-- 6 of 14 --

2020 Sector Guidance* as of 4/29/20(1)
7
* 	2020 guidance contemplates Northrop Grumman is selected for the next phase of the Ground Based Strategic Deterrent program in accordance with the U.S. Air Force’s current
acquisition strategy.
(1) 	2020 financial guidance, as well as outlook, trends, expectations and other forward looking statements provided by the company for 2020 and beyond, reflect the company's
judgment based on the information available to the company at the time of this release. The company is updating its 2020 financial guidance in light of both the impacts we have
experienced to date from the global COVID-19 pandemic (as discussed in the company’s Form 10-Q), and what we currently anticipate, based on what we understand today, to be
the impacts on the company for the remainder of the year. The company’s updated financial guidance assumes generally that the most significant adverse impacts from the
pandemic on the company’s business, financial position, results of operations or cash flows will occur in the second quarter of 2020. However, we cannot predict how the pandemic
will evolve or what impact it will continue to have, and there can be no assurance that the company’s underlying assumptions are correct. As discussed more fully in our Form 10-Q
and among other factors, disruptions to the company’s operations (or those of its customers or supply chain), additional costs, disruptions in the market, and impacts on programs or
payments relating to the global COVID-19 pandemic, today and as it may evolve, can be expected to affect the company’s ability to achieve guidance or meet expectations. In
addition, the government budget, appropriations and procurement processes can impact our customers, programs and financial results. These processes, including the timing of
appropriations and the occurrence of an extended continuing resolution and/or prolonged government shutdown, as well as a breach of the debt ceiling, can impact the company's
ability to achieve guidance or meet expectations.
Sector 	Sales 	OM Rate
Aeronautics Systems 	Low $11B 	~10%
Defense Systems 	Mid $7B 	Mid 10%
Mission Systems 	High $9B 	Low to Mid 14%
Space Systems 	Low $8B 	Low to Mid 10%

-- 7 of 14 --

2020 Guidance* as of 4/29/20(1)
8
Sales ($B) 	35.0 – 35.4
Segment operating margin rate (2) 	11.3 – 11.5%
Total Net FAS/CAS pension adjustment ($B) (3) 	~1.6
Unallocated corporate expense ($M)
Intangible asset amortization and PP&E step-up depreciation 	~315
Other items 	~250
Operating margin rate 	10.8 – 11.0%
Interest expense ($M) 	~590
Effective tax rate 	~16.5%
Weighted average diluted shares outstanding 	~168M
MTM-adjusted EPS (2) 	$21.80 – $22.20
Capital expenditures ($B) 	~1.35
Free cash flow ($B) (2) 	3.15 – 3.45
* 	2020 guidance contemplates Northrop Grumman is selected for the next phase of the Ground Based Strategic Deterrent program in accordance with the U.S. Air Force’s current
acquisition strategy.
(1) 	2020 financial guidance, as well as outlook, trends, expectations and other forward looking statements provided by the company for 2020 and beyond, reflect the company's
judgment based on the information available to the company at the time of this release. The company is updating its 2020 financial guidance in light of both the impacts we have
experienced to date from the global COVID-19 pandemic (as discussed in the company’s Form 10-Q), and what we currently anticipate, based on what we understand today, to be
the impacts on the company for the remainder of the year. The company’s updated financial guidance assumes generally that the most significant adverse impacts from the
pandemic on the company’s business, financial position, results of operations or cash flows will occur in the second quarter of 2020. However, we cannot predict how the pandemic
will evolve or what impact it will continue to have, and there can be no assurance that the company’s underlying assumptions are correct. As discussed more fully in our Form 10-Q
and among other factors, disruptions to the company’s operations (or those of its customers or supply chain), additional costs, disruptions in the market, and impacts on programs or
payments relating to the global COVID-19 pandemic, today and as it may evolve, can be expected to affect the company’s ability to achieve guidance or meet expectations. In
addition, the government budget, appropriations and procurement processes can impact our customers, programs and financial results. These processes, including the timing of
appropriations and the occurrence of an extended continuing resolution and/or prolonged government shutdown, as well as a breach of the debt ceiling, can impact the company's
ability to achieve guidance or meet expectations.
(2) 	Non-GAAP metric. See Appendix.
(3) 	Total Net FAS/CAS pension adjustment is presented as a single amount consistent with our historical presentation, and includes $800 million of expected CAS pension cost and
$800 million of expected FAS pension benefit. $410 million of FAS (service-related) pension cost is reflected in operating income and $1,210 million of FAS (non-service) pension
benefit is reflected below operating income. CAS pension cost continues to be recorded in operating income.

-- 8 of 14 --

COVID-19 related assumptions
9
• 	Closely monitoring and taking actions to mitigate evolving COVID-19
related impacts
• 	Updated guidance reflects the following assumptions:
• 	Increased costs of COVID-19 related impacts to be offset by other
cost reductions
• 	Supply chain and labor impacts greatest in Q2 2020, expected to
impact revenue and segment margin rate in the quarter
• 	Operational pace recovers in 2H 2020
• 	U.S. Government and primes continue timely payment
• 	Marketable securities experience no further losses

-- 9 of 14 --

Segment Operations 	~(.35)
Interest Expense, net 	~(.30)
Marketable Securities Loss 	~(.30)
2020 EPS Guidance as of 1/30/2020 	$22.75 - $23.15
2020 EPS Guidance as of 4/29/2020 	$21.80 - $22.20
2020E MTM-adjusted EPS(1) Bridge
10
(1)
(1)
(1) Non-GAAP metric. See Appendix.
(2) Includes negative returns on marketable securities related to non-qualified benefit plans and other non-operating assets.
(2)

-- 10 of 14 --

Appendix
11

-- 11 of 14 --

Non-GAAP Definitions
Non-GAAP Financial Measures Disclosure: This presentation contains non-GAAP (accounting principles generally
accepted in the United States of America) financial measures, as defined by SEC (Securities and Exchange Commission)
Regulation G and indicated by a footnote in the presentation. Definitions for the non-GAAP measures are provided below
and reconciliations are provided in this presentation. Other companies may define these measures differently or may
utilize different non-GAAP measures.
MTM-adjusted net earnings: Net earnings excluding MTM (expense) benefit and related tax impacts. This measure may
be useful to investors and other users of our financial statements as a supplemental measure in evaluating the company’s
underlying financial performance by presenting the company’s operating results before the non-operational impact of
pension and OPB actuarial gains and losses. This measure is also consistent with how management views the underlying
performance of the business as the impact of MTM accounting is not considered in management’s assessment of the
company's operating performance or in its determination of incentive compensation awards.
MTM-adjusted diluted EPS: Diluted earnings per share excluding the per share impact of any potential MTM (expense)
benefit and related tax impacts. This measure may be useful to investors and other users of our financial statements as a
supplemental measure in evaluating the company’s underlying financial performance per share by presenting the
company’s diluted earnings per share results before the non-operational impact of pension and OPB actuarial gains and
losses.
Segment operating income: Total earnings from our four segments, including allocated pension expense recognized
under CAS, and excluding unallocated corporate items and FAS pension expense. This measure may be useful to
investors and other users of our financial statements as a supplemental measure in evaluating the financial performance
and operational trends of our sectors. This measure should not be considered in isolation or as an alternative to operating
results presented in accordance with GAAP.
Segment operating margin rate: Segment operating income as defined above, divided by sales. This measure may be
useful to investors and other users of our financial statements as a supplemental measure in evaluating the financial
performance and operational trends of our sectors. This measure should not be considered in isolation or as an
alternative to operating results presented in accordance with GAAP.
Free cash flow: Net cash provided by operating activities less capital expenditures. We use free cash flow as a key
factor in our planning for, and consideration of, acquisitions, stock repurchases and the payment of dividends. This
measure may be useful to investors and other users of our financial statements as a supplemental measure of our cash
performance, but should not be considered in isolation, as a measure of residual cash flow available for discretionary
purposes, or as an alternative to operating cash flows presented in accordance with GAAP.
12

-- 12 of 14 --

Non-GAAP Reconciliations –
Segment Operating Income
13

-- 13 of 14 --

14

-- 14 of 14 --